EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA)

Yi Li, Andrew D Berti iD, Wessam Abdelhady, Yan Q Xiong

Antibiotics · 13.02.2025 · 14 (2) · 191

DOI: 10.3390/antibiotics14020191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 13.02.2025. Verfasst von Yi Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institutes of Health/National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Persistent methicillin-resistant Staphylococcus aureus (MRSA) endovascular infections present a significant clinical therapeutic challenge. Prophages are increasingly recognized as important genetic factors influencing the pathogenicity of S. aureus, yet their role in antibiotic persistence in MRSA remains underexplored. Our previous work demonstrated that prophage ϕSA169 promotes vancomycin (VAN) persistence in an experimental model of endocarditis caused by MRSA strains with a clonal complex (CC) 45 genetic background. However, it is unknown whether this persistence-promoting effect of ϕSA169 extends to other clinically relevant MRSA lineages. This study aims to elucidate the role of ϕSA169 in influencing VAN persistence across diverse MRSA genetic backgrounds.

Methods

A pilot analysis of clinical data suggested that patients infected by MRSA containing ϕSA169-like prophage appear to have worse clinical outcomes. Thus, we lysogenized representative clinical resolving bacteremia (RB) MRSA strains with ϕSA169 and evaluated phenotypes closely associated with VAN persistence, including VAN susceptibility, biofilm formation, and the efficacy of VAN treatment in an experimental infective endocarditis (IE) model. Each ϕSA169 lysogenic strain was compared to its isogenic MRSA parental counterpart. Results: ϕSA169 lysogeny significantly promotes biofilm formation and enhances survival to VAN exposure under human-mimicking conditions for RB strains from CC5 and CC30. ϕSA169 lysogeny significantly reduces VAN effectiveness in the IE model due to RB lysogen from CC5 despite no detectable impact on VAN MICs.

Conclusions

These results indicate that ϕSA169 promotes VAN persistence across clonal backgrounds, likely through biofilm formation and VAN tolerance. Targeting prophage could provide new strategies to combat persistent MRSA infections.

Schlagwörter

Stichwörter der Autor:innen

MRSA endovascular infectionsprophagevancomycin persistence

Autor:innen und Institutionen

  • The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, CA 90502, USA.
  • Department of Pharmacy Practice, Wayne State University College of Pharmacy and Health Sciences, Detroit, MI 48201, USA.
  • David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA.

ORCID-Profile: Andrew D Berti

Förderung

  • NIAID NIH HHS
  • National Institutes of Health/National Institute of Allergy and Infectious Diseases

Zitieren

APA

Li, Y., Berti, A. D., Abdelhady, W., & Xiong, Y. Q. (2025). Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics, 14(2), 191. https://doi.org/10.3390/antibiotics14020191

Vancouver

Li Y, Berti AD, Abdelhady W, Xiong YQ. Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA). Antibiotics. 2025;14(2):191. doi:10.3390/antibiotics14020191

BibTeX
@article{Li2025,
  author = {Li, Yi and Berti, Andrew D and Abdelhady, Wessam and Xiong, Yan Q},
  title = {Prophage ϕSA169 Enhances Vancomycin Persistence in Methicillin-Resistant Staphylococcus aureus (MRSA)},
  journal = {Antibiotics},
  year = {2025},
  volume = {14},
  number = {2},
  pages = {191},
  doi = {10.3390/antibiotics14020191}
}
Kostenlos starten →